Literature DB >> 15206998

Alprazolam is relatively more toxic than other benzodiazepines in overdose.

Geoffrey K Isbister1, Luke O'Regan, David Sibbritt, Ian M Whyte.   

Abstract

AIMS: To describe alprazolam poisoning and the relative toxicity of alprazolam compared with other benzodiazepines.
METHODS: A database of consecutive poisoning admissions to a regional toxicology service was searched to identify consecutive benzodiazepine deliberate self poisonings, which were coded as alprazolam, diazepam or other benzodiazepine. Major outcomes used were length of stay (LOS), intensive care (ICU) admission, coma (GCS < 9), flumazenil administration and requirement for mechanical ventilation. Prescription data were obtained for benzodiazepines for the study period.
RESULTS: There were 2063 single benzodiazepine overdose admissions: 131 alprazolam overdoses, 823 diazepam overdoses and 1109 other benzodiazepine overdoses. The median LOS for alprazolam overdoses was 19 h which was 1.27 (95% CI 1.04, 1.54) times longer compared with other benzodiazepines by multiple linear regression. For patients with alprazolam overdoses, 22% were admitted to ICU which was 2.06 (95% CI 1.27, 3.33) times more likely compared with other benzodiazepines after multivariate analysis adjusting for age, dose, gender, time to ingestion and co-ingested drugs. Flumazenil was administered to 14% of alprazolam patients and 16% were ventilated, which was significantly more than for other benzodiazepine overdoses (8% and 11%, respectively). Twelve percent of alprazolam overdoses had a GCS < 9 compared with 10% for other benzodiazepines. From benzodiazepine prescription data, total alprazolam prescriptions in Australia increased from 0.13 million in 1992 to 0.41 million in 2001. Eighty five percent of prescriptions were for panic disorder, anxiety, depression or mixed anxiety/depression.
CONCLUSIONS: Alprazolam was significantly more toxic than other benzodiazepines. The increased prescription of alprazolam to groups with an increased risk of deliberate self poisoning is concerning and needs review.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15206998      PMCID: PMC1884537          DOI: 10.1111/j.1365-2125.2004.02089.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  34 in total

1.  Valproate overdose: a comparative cohort study of self poisonings.

Authors:  Geoffrey K Isbister; Corrine R Balit; Ian M Whyte; Andrew Dawson
Journal:  Br J Clin Pharmacol       Date:  2003-04       Impact factor: 4.335

2.  Panic disorders and the listing of alprazolam on authority on the PBS. Beware of overdiagnosis.

Authors:  A Mant
Journal:  Aust Fam Physician       Date:  1994-04

Review 3.  1992 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Authors:  T L Litovitz; K C Holm; C Clancy; B F Schmitz; L R Clark; G M Oderda
Journal:  Am J Emerg Med       Date:  1993-09       Impact factor: 2.469

4.  1993 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Authors:  T L Litovitz; L R Clark; R A Soloway
Journal:  Am J Emerg Med       Date:  1994-09       Impact factor: 2.469

5.  Acute overdosage with benzodiazepine derivatives.

Authors:  D J Greenblatt; M D Allen; B J Noel; R I Shader
Journal:  Clin Pharmacol Ther       Date:  1977-04       Impact factor: 6.875

6.  Self-poisoning in Newcastle, 1987-1992.

Authors:  N A Buckley; I M Whyte; A H Dawson; P R McManus; N W Ferguson
Journal:  Med J Aust       Date:  1995-02-20       Impact factor: 7.738

7.  Fatal poisonings attributed to benzodiazepines in Britain during the 1980s.

Authors:  M Serfaty; G Masterton
Journal:  Br J Psychiatry       Date:  1993-09       Impact factor: 9.319

Review 8.  A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.

Authors:  J M Jonas; M S Cohon
Journal:  J Clin Psychiatry       Date:  1993-10       Impact factor: 4.384

9.  Comparison of the fatal toxicity index of zopiclone with benzodiazepines.

Authors:  David M Reith; John Fountain; Rebecca McDowell; Murray Tilyard
Journal:  J Toxicol Clin Toxicol       Date:  2003

10.  Relative toxicity of benzodiazepines in overdose.

Authors:  N A Buckley; A H Dawson; I M Whyte; D L O'Connell
Journal:  BMJ       Date:  1995-01-28
View more
  21 in total

Review 1.  A Review of Alprazolam Use, Misuse, and Withdrawal.

Authors:  Nassima Ait-Daoud; Allan Scott Hamby; Sana Sharma; Derek Blevins
Journal:  J Addict Med       Date:  2018 Jan/Feb       Impact factor: 3.702

2.  Chronic ethanol potentiates the effect of neuropeptide s in the basolateral amygdala and shows increased anxiolytic and anti-depressive effects.

Authors:  Johan Enquist; Madeline Ferwerda; Anuradha Madhavan; Derek Hok; Jennifer L Whistler
Journal:  Neuropsychopharmacology       Date:  2012-06-27       Impact factor: 7.853

3.  Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg.

Authors:  Tim R M Leufkens; Annemiek Vermeeren; Beitske E Smink; Peter van Ruitenbeek; Johannes G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2007-01-12       Impact factor: 4.530

Review 4.  Flumazenil, naloxone and the 'coma cocktail'.

Authors:  Marco L A Sivilotti
Journal:  Br J Clin Pharmacol       Date:  2015-09-21       Impact factor: 4.335

5.  Nonmedical use of alprazolam in the UK: Results from a nationally representative survey.

Authors:  Joanna Hockenhull; Elise Amioka; Joshua C Black; Colleen M Haynes; Paul I Dargan; Richard C Dart; David M Wood
Journal:  Br J Clin Pharmacol       Date:  2019-06-05       Impact factor: 4.335

6.  The α2,3-selective potentiator of GABAA receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in rats.

Authors:  J M Witkin; R Cerne; P G Davis; K B Freeman; J M do Carmo; J K Rowlett; K R Methuku; A Okun; S D Gleason; X Li; M J Krambis; M Poe; G Li; J M Schkeryantz; R Jahan; L Yang; W Guo; L K Golani; W H Anderson; J T Catlow; T M Jones; F Porreca; J L Smith; K L Knopp; J M Cook
Journal:  Pharmacol Biochem Behav       Date:  2019-02-27       Impact factor: 3.533

7.  Dual efficacy of delta opioid receptor-selective ligands for ethanol drinking and anxiety.

Authors:  Richard M van Rijn; Daniela I Brissett; Jennifer L Whistler
Journal:  J Pharmacol Exp Ther       Date:  2010-07-06       Impact factor: 4.030

8.  Prevalence and correlates of co-ingestion of prescription tranquilizers and other psychoactive substances by U.S. high school seniors: Results from a national survey.

Authors:  Ty S Schepis; Brady T West; Christian J Teter; Sean Esteban McCabe
Journal:  Addict Behav       Date:  2015-08-12       Impact factor: 3.913

Review 9.  Management of benzodiazepine misuse and dependence.

Authors:  Jonathan Brett; Bridin Murnion
Journal:  Aust Prescr       Date:  2015-10-01

10.  Glasgow coma scale and its components on admission: are they valuable prognostic tools in acute mixed drug poisoning?

Authors:  N Eizadi Mood; A M Sabzghabaee; Gh Yadegarfar; A Yaraghi; M Ramazani Chaleshtori
Journal:  Crit Care Res Pract       Date:  2011-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.